- VIDD1:
    excelfile: data/neut_assays/plate_reader_data/VIDD1_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2010-age-21
        virus: WT
        dilution_factor: 1.889
        initial_concentration: 0.02647
      F193D:
        serum: 2010-age-21
        virus: F193D
        dilution_factor: 1.889
        initial_concentration: 0.02647
      F193F:
        serum: 2010-age-21
        virus: F193F
        dilution_factor: 1.889
        initial_concentration: 0.02647
      K189D:
        serum: 2010-age-21
        virus: K189D
        dilution_factor: 1.889
        initial_concentration: 0.02647
      L157D:
        serum: 2010-age-21
        virus: L157D
        dilution_factor: 1.889
        initial_concentration: 0.02647

- VIDD2:
    excelfile: data/neut_assays/plate_reader_data/VIDD2_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2009-age-53a
        virus: WT
        dilution_factor: 2
        initial_concentration: 0.025
      L157D:
        serum: 2009-age-53a
        virus: L157D
        dilution_factor: 2
        initial_concentration: 0.025
      K160T:
        serum: 2009-age-53a
        virus: K160T
        dilution_factor: 2
        initial_concentration: 0.025
      F193D:
        serum: 2009-age-53a
        virus: F193D
        dilution_factor: 2
        initial_concentration: 0.025
      F193F:
        serum: 2009-age-53a
        virus: F193F
        dilution_factor: 2
        initial_concentration: 0.025
        
- VIDD3:
    excelfile: data/neut_assays/plate_reader_data/VIDD3_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2009-age-53b
        virus: WT
        dilution_factor: 2
        initial_concentration: 0.025
      L157D:
        serum: 2009-age-53b
        virus: L157D
        dilution_factor: 2
        initial_concentration: 0.025
      K160T:
        serum: 2009-age-53b
        virus: K160T
        dilution_factor: 2
        initial_concentration: 0.025
      F193D:
        serum: 2009-age-53b
        virus: F193D
        dilution_factor: 2
        initial_concentration: 0.025
      F159G:
        serum: 2009-age-53b
        virus: F159G
        dilution_factor: 2
        initial_concentration: 0.025

- VIDD4:
    excelfile: data/neut_assays/plate_reader_data/VIDD4_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2009-age-64
        virus: WT
        dilution_factor: 2.143
        initial_concentration: 0.0233
      F159G:
        serum: 2009-age-64
        virus: F159G
        dilution_factor: 2.143
        initial_concentration: 0.0233
      K189D:
        serum: 2009-age-64
        virus: K189D
        dilution_factor: 2.143
        initial_concentration: 0.0233
      F193D:
        serum: 2009-age-64
        virus: F193D
        dilution_factor: 2.143
        initial_concentration: 0.0233

- VIDD5:
    excelfile: data/neut_assays/plate_reader_data/VIDD5_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2009-age-65
        virus: WT
        dilution_factor: 2.143
        initial_concentration: 0.0233
      F193D:
        serum: 2009-age-65
        virus: F193D
        dilution_factor: 2.143
        initial_concentration: 0.0233
      K160T:
        serum: 2009-age-65
        virus: K160T
        dilution_factor: 2.143
        initial_concentration: 0.0233
      F193F:
        serum: 2009-age-65
        virus: F193F
        dilution_factor: 2.143
        initial_concentration: 0.0233
      N121E:
        serum: 2009-age-65
        virus: N121E
        dilution_factor: 2.143
        initial_concentration: 0.0233
      F159G:
        serum: 2009-age-65
        virus: F159G
        dilution_factor: 2.143
        initial_concentration: 0.0233
        
- 557v1:
    excelfile: data/neut_assays/plate_reader_data/557v1_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2015-age-25-prevacc
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.0238
      F159G:
        serum: 2015-age-25-prevacc
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 0.0238
      R220D:
        serum: 2015-age-25-prevacc
        virus: R220D
        dilution_factor: 2.333
        initial_concentration: 0.0238
      K189D:
        serum: 2015-age-25-prevacc
        virus: K189D
        dilution_factor: 2.333
        initial_concentration: 0.0238

- 557v2:
    excelfile: data/neut_assays/plate_reader_data/557v2_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2015-age-25-vacc
        virus: WT
        dilution_factor: 2.143
        initial_concentration: 0.0025
      F159G:
        serum: 2015-age-25-vacc
        virus: F159G
        dilution_factor: 2.143
        initial_concentration: 0.0025
      F159F:
        serum: 2015-age-25-vacc
        virus: F159F
        dilution_factor: 2.143
        initial_concentration: 0.0025

- 574v1:
    excelfile: data/neut_assays/plate_reader_data/574v1_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2015-age-29-prevacc
        virus: WT
        dilution_factor: 1.889
        initial_concentration: 0.02647
      F159G:
        serum: 2015-age-29-prevacc
        virus: F159G
        dilution_factor: 1.889
        initial_concentration: 0.02647
      K144E:
        serum: 2015-age-29-prevacc
        virus: K144E
        dilution_factor: 1.889
        initial_concentration: 0.02647

- 574v2:
    excelfile: data/neut_assays/plate_reader_data/574v2_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2015-age-29-vacc
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K144E:
        serum: 2015-age-29-vacc
        virus: K144E
        dilution_factor: 2.333
        initial_concentration: 0.0125
      F159G:
        serum: 2015-age-29-vacc
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 0.0125

- 589v2:
    excelfile: data/neut_assays/plate_reader_data/589v2_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2015-age-48-vacc
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K189D:
        serum: 2015-age-48-vacc
        virus: K189D
        dilution_factor: 2.333
        initial_concentration: 0.0125
      F159G:
        serum: 2015-age-48-vacc
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 0.0125
      R220D:
        serum: 2015-age-48-vacc
        virus: R220D
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K144E:
        serum: 2015-age-48-vacc
        virus: K144E
        dilution_factor: 2.333
        initial_concentration: 0.0125

- 571v2:
    excelfile: data/neut_assays/plate_reader_data/571v2_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: 2015-age-49-vacc
        virus: WT
        dilution_factor: 2
        initial_concentration: 0.025
      G75(HA2)H:
        serum: 2015-age-49-vacc
        virus: G75(HA2)H
        dilution_factor: 2
        initial_concentration: 0.025

- ferret-Pitt-1-postinf:
    excelfile: data/neut_assays/plate_reader_data/fPitt1postinf_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: ferret-Pitt-1-postinf
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K189D:
        serum: ferret-Pitt-1-postinf
        virus: K189D
        dilution_factor: 2.333
        initial_concentration: 0.0125
      F193D:
        serum: ferret-Pitt-1-postinf
        virus: F193D
        dilution_factor: 2.333
        initial_concentration: 0.0125
      F193F:
        serum: ferret-Pitt-1-postinf
        virus: F193F
        dilution_factor: 2.333
        initial_concentration: 0.0125
      F159G:
        serum: ferret-Pitt-1-postinf
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K144E:
        serum: ferret-Pitt-1-postinf
        virus: K144E
        dilution_factor: 2.333
        initial_concentration: 0.0125

- ferret-Pitt-2-postinf:
    excelfile: data/neut_assays/plate_reader_data/fPitt2postinf_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: ferret-Pitt-2-postinf
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K189D:
        serum: ferret-Pitt-2-postinf
        virus: K189D
        dilution_factor: 2.333
        initial_concentration: 0.0125
      F193D:
        serum: ferret-Pitt-2-postinf
        virus: F193D
        dilution_factor: 2.333
        initial_concentration: 0.0125
      K144E:
        serum: ferret-Pitt-2-postinf
        virus: K144E
        dilution_factor: 2.333
        initial_concentration: 0.0125

- ferret-Pitt-3-postinf:
    excelfile: data/neut_assays/plate_reader_data/fPitt3postinf_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: ferret-Pitt-3-postinf
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.0238
      K189D:
        serum: ferret-Pitt-3-postinf
        virus: K189D
        dilution_factor: 2.333
        initial_concentration: 0.0238
      F193D:
        serum: ferret-Pitt-3-postinf
        virus: F193D
        dilution_factor: 2.333
        initial_concentration: 0.0238
      K160T:
        serum: ferret-Pitt-3-postinf
        virus: K160T
        dilution_factor: 2.333
        initial_concentration: 0.0238
      L157D:
        serum: ferret-Pitt-3-postinf
        virus: L157D
        dilution_factor: 2.333
        initial_concentration: 0.0238

- ferret-WHO-Victoria2011:
    excelfile: data/neut_assays/plate_reader_data/WHOVic11_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: ferret-WHO-Victoria2011
        virus: WT
        dilution_factor: 2
        initial_concentration: 0.025
      K189D:
        serum: ferret-WHO-Victoria2011
        virus: K189D
        dilution_factor: 2
        initial_concentration: 0.025
      F193D:
        serum: ferret-WHO-Victoria2011
        virus: F193D
        dilution_factor: 2
        initial_concentration: 0.025
      F159G:
        serum: ferret-WHO-Victoria2011
        virus: F159G
        dilution_factor: 2
        initial_concentration: 0.025
      K160T:
        serum: ferret-WHO-Victoria2011
        virus: K160T
        dilution_factor: 2
        initial_concentration: 0.025

- antibody-5A01:
    excelfile: data/neut_assays/plate_reader_data/mAb_5A01_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: antibody-5A01
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 1
      F159G:
        serum: antibody-5A01
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 1
      F159F:
        serum: antibody-5A01
        virus: F159F
        dilution_factor: 2.333
        initial_concentration: 1
      K160T:
        serum: antibody-5A01
        virus: K160T
        dilution_factor: 2.333
        initial_concentration: 1

- antibody-3C06:
    excelfile: data/neut_assays/plate_reader_data/mAb_3C06_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: antibody-3C06
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.5
      F159G:
        serum: antibody-3C06
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 0.5
      K160T:
        serum: antibody-3C06
        virus: K160T
        dilution_factor: 2.333
        initial_concentration: 0.5

- antibody-3C04:
    excelfile: data/neut_assays/plate_reader_data/mAb_3C04_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: antibody-3C04
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.5
      K160T:
        serum: antibody-3C04
        virus: K160T
        dilution_factor: 2.333
        initial_concentration: 0.5
      K160S:
        serum: antibody-3C04
        virus: K160S
        dilution_factor: 2.333
        initial_concentration: 0.5

- antibody-4C01:
    excelfile: data/neut_assays/plate_reader_data/mAb_4C01_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: antibody-4C01
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 0.5
      F193D:
        serum: antibody-4C01
        virus: F193D
        dilution_factor: 2.333
        initial_concentration: 0.5
      F193F:
        serum: antibody-4C01
        virus: F193F
        dilution_factor: 2.333
        initial_concentration: 0.5
      K160T:
        serum: antibody-4C01
        virus: K160T
        dilution_factor: 2.333
        initial_concentration: 0.5

- antibody-4F03:
    excelfile: data/neut_assays/plate_reader_data/mAb_4F03_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: antibody-4F03
        virus: WT
        dilution_factor: 2.333
        initial_concentration: 3
      N121E:
        serum: antibody-4F03
        virus: N121E
        dilution_factor: 2.333
        initial_concentration: 3
      F193D:
        serum: antibody-4F03
        virus: F193D
        dilution_factor: 2.333
        initial_concentration: 3
      F159G:
        serum: antibody-4F03
        virus: F159G
        dilution_factor: 2.333
        initial_concentration: 3

- antibody-1C04:
    excelfile: data/neut_assays/plate_reader_data/mAb_1C04_NeutralizationAssay.xlsx
    sheet_mapping:
      WT:
        serum: antibody-1C04
        virus: WT
        dilution_factor: 2.6
        initial_concentration: 5
      K82A:
        serum: antibody-1C04
        virus: K82A
        dilution_factor: 2.6
        initial_concentration: 5
